| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2022 | Feb 1, 2022 | Outlook Therapeutics, Inc. | Director | Buy | 92.5 | +2,500,000 | 4.69% | ✗ | $3.1M |
| Nov 29, 2021 | Dec 1, 2021 | Outlook Therapeutics, Inc. | Director | Buy | 100.0 | +16,000,000 | 135.20% | ✗ | $20M |
| Feb 2, 2021 | Feb 2, 2021 | Outlook Therapeutics, Inc. | Director | Buy | 100.0 | +8,360,000 | 339.75% | ✗ | $8.4M |